Evidence map›Paper›PMID 42156789›Full record

ArticleNature communications2026

Bridged scaffold editing of carbocycles and heterocycles.

Jiaming Li, Yuyan Yang, Zeguang Dai, Siyu Chen, Sijie Xiong, Guanghui Li, Linwei Zeng, Sunliang Cui

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiaming Li *College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Yuyan Yang *College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Zeguang Dai *College of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, China.
Siyu ChenCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Sijie XiongCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Guanghui LiCollege of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, China.
Linwei ZengDepartment of Chemistry, National University of Singapore, Singapore, Singapore. lwzeng@nus.edu.sg.ORCID http://orcid.org/0000-0002-2399-8008
Sunliang CuiCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. slcui@zju.edu.cn.ORCID http://orcid.org/0000-0001-9407-5190

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22277106National Natural Science Foundation of China (National Science Foundation of China) 82504610National Natural Science Foundation of China (National Science Foundation of China) U24A20801Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LMS25H300001Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LR23H300001
6 · The paper itself

Abstract

Bridged frameworks are widely recognized as privileged motifs in natural products and pharmaceuticals, and their distinctive three-dimensional architectures often underpin target recognition and bioactivity. However, their preparation remains a formidable challenge, with most strategies relying on either linear multi-step syntheses or structurally specialized substrates. Here we report a bridged scaffold editing strategy for heterocycles and carbocycles, which employs formaldehyde and ureas in a distinct multicomponent reaction, toward modular and efficient construction of diverse bridged polycycles. Notably, this protocol enables concurrent C(sp²)-H and unactivated C(sp³)-H functionalization, for directly assembling bridged polycyclic products from planar or quasi-planar cyclic substrates through regio- and diastereoselective multiple bond formations. Experimental and computational studies collectively elucidate the plausible reaction pathways underlying these transformations. By offering rapid and general access to three-dimensional polycyclic skeletons, this approach expands the molecular editing toolbox and provides a versatile platform for generating structurally unique compounds with potential applications in drug discovery.

Indexed as

Heterocyclic CompoundsBiological ProductsCyclizationFormaldehydeMolecular StructureStereoisomerismUreaBiological ProductsFormaldehydeHeterocyclic CompoundsUrea

Identifiers

PMID42156789
PMCPMC13381971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.